Lunxu Liu

发表

Drug-tolerant persister cells in cancer: the cutting edges and future directions

C. Robert, Lu Li, H. Peng, 2023, Nature Reviews Clinical Oncology.

Risk factors and a prognostic model for patients with borderline resectable locally advanced T3–4N0–1 non-small cell lung cancer: a population-based study

Chenglin Guo, Hongjin Lai, Lunxu Liu, 2023, Translational cancer research.

Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.

N. Yang, Jin-lu Shan, Xiaohua Hu, 2024, JAMA.

Withdrawal Notice

Lunxu Liu, Yue Yuan, Q. Pu, 2022, Cancer medicine.

The Clinical Outcomes of Thoracoscopic Versus Open Lobectomy for Non-Small-Cell Lung Cancer After Neoadjuvant Therapy: A Multi-Center Retrospective Cohort Study.

Yang Liu, Jin-lin Cao, Chong Zhang, 2023, Clinical lung cancer.

Ligand recognition and G-protein coupling of trace amine receptor TAAR1

Lin Cheng, Xiaohui Wang, Xiaowen Tian, 2023, Nature.

Trackplot: A flexible toolkit for combinatorial analysis of genomic data

Yiming Zhang, Yuan Wang, Ran Zhou, 2023, PLoS Comput. Biol..

Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective

F. Dai, Lunxu Liu, Nanzhi Luo, 2024, Thoracic cancer.

Multicellular ecotypes shape progression of lung adenocarcinoma from ground-glass opacity toward advanced stages

Senyi Deng, Zhenyu Yang, J. Mei, 2024, Cell reports. Medicine.

Thoracic surgeons' insights: Improving thoracic surgery outcomes during the Coronavirus Disease 2019 pandemic

Lunxu Liu, Shugeng Gao, Ke-Neng Chen, 2020, The Journal of Thoracic and Cardiovascular Surgery.

Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study

Zhenyu Yang, Shiyou Wei, J. Mei, 2023, Thoracic cancer.